High blood pressure is a well-known cardiovascular risk factor that is resp
onsible for an elevated morbidity and mortality. However, although efficaci
ous drugs for treatment and numerous and updated scientific training progra
ms are available, the reality is that only a low percentage of patients are
followed up in accordance with the rates which are presently considered no
rmal. The purpose of these guidelines is to provide medical guidance for th
e prevention, detection and evaluation of hypertension, and to provide the
best diagnosis and treatment. The factors involved in cardiovascular compli
cations in the hypertensive patient are multiple. That is why this report p
laces more emphasis in the individual cardiovascular risk stratification as
part of the treatment strategy. The information obtained in the most recen
t studies published confirms the interest in achieving the greatest decreas
e in rates of blood pressure. This treatment to lower levels is especially
useful in the high-risk subgroup. It maintains the necessity of nonpharmaco
logical measures or lifestyle modifications in all patients with high blood
pressure who either need or do not need drug therapy. AII pharmacological
groups may be used, but it is appropriate to choose the specific antihypert
ensive agent adapted to the clinical and individual situation with the use
of low doses of drugs to initiate therapy and the use of appropriate drug c
ombinations.